Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

Sargassum fusiforme fucoidan modifies the gut microbiota during alleviation of streptozotocin-induced hyperglycemia in mice.

Cheng Y, Sibusiso L, Hou L, Jiang H, Chen P, Zhang X, Wu M, Tong H.

Int J Biol Macromol. 2019 Jun 15;131:1162-1170. doi: 10.1016/j.ijbiomac.2019.04.040. Epub 2019 Apr 8.

PMID:
30974142
2.

A Randomized Placebo-controlled Trial of an Oral Preparation of High Molecular Weight Fucoidan in Patients with Type 2 Diabetes with Evaluation of Taste Sensitivity.

Sakai C, Abe S, Kouzuki M, Shimohiro H, Ota Y, Sakinada H, Takeuchi T, Okura T, Kasagi T, Hanaki K.

Yonago Acta Med. 2019 Mar 28;62(1):14-23. eCollection 2019 Mar.

3.

In vitro and in silico inhibition properties of fucoidan against α-amylase and α-D-glucosidase with relevance to type 2 diabetes mellitus.

S LS, Raghu C, H A A, P A.

Carbohydr Polym. 2019 Apr 1;209:350-355. doi: 10.1016/j.carbpol.2019.01.039. Epub 2019 Jan 14.

PMID:
30732817
4.

Structure Analysis and Anti-Tumor and Anti-Angiogenic Activities of Sulfated Galactofucan Extracted from Sargassum thunbergii.

Jin W, Wu W, Tang H, Wei B, Wang H, Sun J, Zhang W, Zhong W.

Mar Drugs. 2019 Jan 11;17(1). pii: E52. doi: 10.3390/md17010052.

5.

Development of mutlifunctional nanoparticles self-assembled from trimethyl chitosan and fucoidan for enhanced oral delivery of insulin.

Tsai LC, Chen CH, Lin CW, Ho YC, Mi FL.

Int J Biol Macromol. 2019 Apr 1;126:141-150. doi: 10.1016/j.ijbiomac.2018.12.182. Epub 2018 Dec 23.

PMID:
30586591
6.

Algal Polysaccharides as Therapeutic Agents for Atherosclerosis.

Patil NP, Le V, Sligar AD, Mei L, Chavarria D, Yang EY, Baker AB.

Front Cardiovasc Med. 2018 Oct 26;5:153. doi: 10.3389/fcvm.2018.00153. eCollection 2018. Review.

7.

Effect of a Fucoidan Extract on Insulin Resistance and Cardiometabolic Markers in Obese, Nondiabetic Subjects: A Randomized, Controlled Trial.

Wright CM, Bezabhe W, Fitton JH, Stringer DN, Bereznicki LRE, Peterson GM.

J Altern Complement Med. 2019 Mar;25(3):346-352. doi: 10.1089/acm.2018.0189. Epub 2018 Oct 12.

PMID:
30312135
8.

Phycochemical Constituents and Biological Activities of Fucus spp.

Catarino MD, Silva AMS, Cardoso SM.

Mar Drugs. 2018 Jul 27;16(8). pii: E249. doi: 10.3390/md16080249. Review.

9.

Low molecular-weight fucoidan protects against hindlimb ischemic injury in type 2 diabetic mice through enhancing endothelial nitric oxide synthase phosphorylation.

Liu T, Wang Z, Chen X, You H, Xue J, Cai D, Zheng Y, Xu Y, Luo D.

J Diabetes. 2018 Nov;10(11):820-834. doi: 10.1111/1753-0407.12667. Epub 2018 May 17.

PMID:
29633569
10.

Effects of fucoidan on diabetic rat testicular tissue.

Ersoy O, Kizilay G.

Biotech Histochem. 2018;93(4):277-285. doi: 10.1080/10520295.2018.1434679. Epub 2018 Mar 7.

PMID:
29513110
11.

Low molecular weight fucoidan attenuates liver injury via SIRT1/AMPK/PGC1α axis in db/db mice.

Zheng Y, Liu T, Wang Z, Xu Y, Zhang Q, Luo D.

Int J Biol Macromol. 2018 Jun;112:929-936. doi: 10.1016/j.ijbiomac.2018.02.072. Epub 2018 Feb 13.

PMID:
29447962
12.

Low molecular weight fucoidan ameliorates hindlimb ischemic injury in type 2 diabetic rats.

Wang Z, Liu T, Chen X, You H, Zhang Q, Xue J, Zheng Y, Luo D.

J Ethnopharmacol. 2018 Jan 10;210:434-442. doi: 10.1016/j.jep.2017.09.014. Epub 2017 Sep 14.

PMID:
28917976
13.

Fucoidan ameliorates pancreatic β-cell death and impaired insulin synthesis in streptozotocin-treated β cells and mice via a Sirt-1-dependent manner.

Yu WC, Chen YL, Hwang PA, Chen TH, Chou TC.

Mol Nutr Food Res. 2017 Oct;61(10). doi: 10.1002/mnfr.201700136. Epub 2017 Jun 8.

PMID:
28493611
14.
15.

Fucoidan inhibits LPS-induced inflammation in vitro and during the acute response in vivo.

Park J, Cha JD, Choi KM, Lee KY, Han KM, Jang YS.

Int Immunopharmacol. 2017 Feb;43:91-98. doi: 10.1016/j.intimp.2016.12.006. Epub 2016 Dec 14.

PMID:
27987467
16.

Marine Algae as a Potential Source for Anti-Obesity Agents.

Wan-Loy C, Siew-Moi P.

Mar Drugs. 2016 Dec 7;14(12). pii: E222. Review.

17.

Low molecular weight fucoidan ameliorates streptozotocin-induced hyper-responsiveness of aortic smooth muscles in type 1 diabetes rats.

Liang Z, Zheng Y, Wang J, Zhang Q, Ren S, Liu T, Wang Z, Luo D.

J Ethnopharmacol. 2016 Sep 15;191:341-349. doi: 10.1016/j.jep.2016.06.054. Epub 2016 Jun 21.

PMID:
27346541
18.

Low molecular weight fucoidan modulates P-selectin and alleviates diabetic nephropathy.

Xu Y, Zhang Q, Luo D, Wang J, Duan D.

Int J Biol Macromol. 2016 Oct;91:233-40. doi: 10.1016/j.ijbiomac.2016.05.081. Epub 2016 May 24.

PMID:
27234491
19.

Looking Beyond the Terrestrial: The Potential of Seaweed Derived Bioactives to Treat Non-Communicable Diseases.

Collins KG, Fitzgerald GF, Stanton C, Ross RP.

Mar Drugs. 2016 Mar 18;14(3). pii: E60. doi: 10.3390/md14030060. Review.

20.

Fucoidan from Acaudina molpadioides protects pancreatic islet against cell apoptosis via inhibition of inflammation in type 2 diabetic mice.

Wang J, Hu S, Wang J, Li S, Jiang W.

Food Sci Biotechnol. 2016 Feb 29;25(1):293-300. doi: 10.1007/s10068-016-0042-6. eCollection 2016.

Supplemental Content

Loading ...
Support Center